Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine for COVID-19 Prophylaxis in Egyptian Healthcare Workers
NCT04350931Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BCG Vaccine with Placebo (2 arms). Primary endpoints: Incidence of confirmed COVID-19 at 9 months and Effectiveness of BCG vaccine at 9 months. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04350931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04350931.